Table 2.
Total N=104 n (%) |
RD N=32 n (%) |
UCB N=72 n (%) |
P-value | |
---|---|---|---|---|
| ||||
Withdrawal of IST* | .51 | |||
Yes | 57 (75) | 16 (67) | 41 (79) | |
No | 2 (3) | 1 (4) | 1 (2) | |
Unknown | 17 (22) | 7 (29) | 10 (19) | |
| ||||
Treatment at relapse | < .01 | |||
Intensive | ||||
Chemotherapy | 29 (28) | 7 (22) | 22 (31) | |
DLI | 12 (12) | 12 (38) | 0 (0) | |
2nd AlloHCT | 11 (11) | 2 (6) | 9 (13) | |
Supportive | 37 (34) | 7 (22) | 30 (42) | |
Unknown | 15 (14) | 4 (13) | 11 (15) |
Abbreviations: IST, immunosuppressive therapy
At relapse only 76 patients have been receiving IST